BridgeBio Pharma, Inc. Common Stock (BBIO) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for BBIO. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|
| BlackRock, Inc. | 14,207,757 | $1.1B | DECREASED |
| Kohlberg Kravis Roberts & Co. L.P. | 13,260,971 | $985M | UNCHANGED |
| JANUS HENDERSON GROUP PLC | 13,179,013 | $979M | INCREASED |
| VIKING GLOBAL INVESTORS LP | 11,842,434 | $879M | DECREASED |
| FARALLON CAPITAL MANAGEMENT LLC | 9,365,463 | $695M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|
| Ali J. Satvat (Director) | AWARD | 5,277 | $364K | 2026-06-22 |
| Ali J. Satvat (Director) | AWARD | 3,990 | | 2026-06-22 |
| Douglas A. Dachille (Director) | AWARD | 5,277 | $364K | 2026-06-22 |
| Douglas A. Dachille (Director) | AWARD | 3,990 | | 2026-06-22 |
| Frank Mccormick (Director) | AWARD | 5,277 | $364K | 2026-06-22 |
Recent Congressional Trades
Full institutional holdings, insider history, and congressional trades for BridgeBio Pharma, Inc. Common Stock on SentiSense.